ODDITY Tech Stock News

NANJING, China, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that opamtistomig (LBL-024), the Company's proprietary PD‑L1/4‑1BB bispecific antibody, has been granted Orphan Drug Designation (ODD) by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of extrapulmonary neuroendocrine...

ODDITY (NASDAQ:ODD) shares jumped 14% on Thursday after the company posted second-quarter results that topped Wall Street estimates and issued a stronger-than-expected full-year profit outlook. The consumer tech company reported revenue of $181 million for the quarter, beating estimates of $178 million but down 25% from a year earlier.

Second quarter net revenue of $181 million, down approximately 25% year-over-year Second quarter adjusted EBITDA of $13 million Second quarter net income of $13 million and second quarter adjusted net income of $11 million Strong liquidity position including cash, cash equivalents and investments of $561 million, and aggregate credit facilities of $350 million which remain undrawn NEW YORK, Sep...

These companies are all expected to show very rapid revenue growth through 2028.

First quarter net revenue of $197.9 million, down approximately 26% year-over-year First quarter adjusted EBITDA of $(7.0) million First quarter net loss of $(21.4) million and first quarter adjusted net loss of $(9.8) million Strong  liquidity position including cash, cash equivalents and investments of $667 .4 million, and aggregate credit facilities of $350 million which remain undrawn NEW Y...

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) (NASDAQ: ODD), today announced that it will release its first quarter 2026 financial results before the market open on Tuesday, June 2, 2026, to be followed by a conference call at 8:30 a.m.

NEW YORK, May 8, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ODDITY Tech Ltd. (NASDAQ: ODD) between February 26, 2025 and February 24, 2026, inclusive (the "Class Period"), of the important May 11, 2026 lead plaintiff deadline.